Predictive Factors for Silibinin Monotherapy in Patients With Chronic Hepatitis C and Nonresponse to PEG-IFN/RBV Therapy

被引：0
|
作者：
Rutter, Karoline
Stattermayer, Albert
Reiberger, Thomas
Aberle, Judith H.
Zinober, Kerstin
Scherzer, Thomas-Matthias
Beinhardt, Sandra
Holzmann, Heidemarie
Steindl-Munda, Petra
Hofer, Harald
Ferenci, Peter
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1257
引用
收藏
页码：S214 / S215
页数：2
相关论文
共 50 条
  • [21] Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study
    Atsukawa, Masanori
    Tsubota, Akihito
    Shimada, Noritomo
    Kondo, Chisa
    Itokawa, Norio
    Nakagawa, Ai
    Hashimoto, Satomi
    Fukuda, Takeshi
    Matsushita, Yoko
    Kidokoro, Hideko
    Narahara, Yoshiyuki
    Nakatsuka, Katsuhisa
    Iwakiri, Katsuhiko
    Kawamoto, Chiaki
    Sakamoto, Choitsu
    HEPATITIS MONTHLY, 2013, 13 (12)
  • [22] ELIGIBILITY 2: A PROSPECTIVE, OBSERVATIONAL, MULTICENTRE STUDY ON OUTCOMES OF PEG-INTERFERON/RIBAVIRIN (PEG-IFN/RBV) IN CHRONIC HEPATITIS C (CHC)
    Vukotic, R.
    Gamal, N.
    Andreone, P.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E45 - E46
  • [23] Protein Pathway Activation Associated with Sustained Virologic Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon (PEG-IFN) and Ribavirin (RBV)
    Younossi, Zobair M.
    Limongi, Dolores
    Stepanova, Maria
    Pierobon, Mariaelena
    Afendy, Arian
    Mehta, Rohini
    Baranova, Ancha
    Liotta, Lance
    Petricoin, Emanuel
    JOURNAL OF PROTEOME RESEARCH, 2011, 10 (02) : 774 - 779
  • [24] IL28B GENOTYPE MAJOR AND RELAPSE OF PREVIOUS PEG-IFN/RBV THERAPY ARE THE CONVINCING PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE IN TELAPREVIR WITH PEG-IFN/RBV THERAPY
    Karino, Y.
    Ozeki, I.
    Toyota, J.
    Imamura, M.
    Tsuge, M.
    Chayama, K.
    Sezaki, H.
    Akuta, N.
    Kumada, H.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S525 - S525
  • [25] Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C
    Sulkowski, Mark S.
    Cooper, Curtis
    Hunyady, Bela
    Jia, Jidong
    Ogurtsov, Pavel
    Peck-Radosavljevic, Markus
    Shiffman, Mitchell L.
    Yurdaydin, Cihan
    Dalgard, Olav
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (04) : 212 - 223
  • [26] Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C
    Mark S. Sulkowski
    Curtis Cooper
    Bela Hunyady
    Jidong Jia
    Pavel Ogurtsov
    Markus Peck-Radosavljevic
    Mitchell L. Shiffman
    Cihan Yurdaydin
    Olav Dalgard
    Nature Reviews Gastroenterology & Hepatology, 2011, 8 : 212 - 223
  • [27] A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy
    Laouenan, C.
    Guedj, J.
    Peytavin, G.
    Nguyen, T. H. Tram
    Lapalus, M.
    Khelifa-Mouri, F.
    Boyer, N.
    Zoulim, F.
    Serfaty, L.
    Bronowicki, J-P
    Martinot-Peignoux, M.
    Lada, O.
    Asselah, T.
    Dorival, C.
    Hezode, C.
    Carrat, F.
    Nicot, F.
    Marcellin, P.
    Mentre, F.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2015, 4 (01): : 37 - 40
  • [28] Early results of peg-IFN α-2a treatment in chronic hemodialysis patients with chronic c hepatitis
    Strain, M. H.
    Patrascu, M.
    Strain, R. D.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S146 - S147
  • [29] ENDOGENOUS INNATE IMMUNITY-IFN PATHWAY IS IMPORTANT FOR THE EFFICIENCY OF PEG-IFN/RBV THERAPY FOR CHRONIC HCV INFECTION
    Yoda, Masayoshi
    Yoda, Ryoko
    Fujino, Tatsuya
    Momosaki, Seiyo
    Amaogase, Yoko
    Yamamoto, Naoko
    Takemoto, Ryosuke
    Yoshimoto, Tsuyoshi
    Miyahara, Toshihiko
    Fukuizumi, Kunitaka
    Harada, Naohika
    Taketomi, Akinobu
    Maehara, Yoshihiko
    Enjoji, Munechiko
    Nakamuta, Makoto
    HEPATOLOGY, 2008, 48 (04) : 1008A - 1008A
  • [30] RBV BLOOD CONCENTRATION AT FIRST WEEK OF PEG-IFN/RBV/TVR COMBINATION THERAPY IS A GOOD PREDICTIVE MARKER OF RENAL DYSFUNCTION AND ANEMIA
    Karino, Y.
    Ozeki, I.
    Hige, S.
    Miyakawa, M.
    Kimura, M.
    Arakawa, T.
    Nakajima, T.
    Kuwata, Y.
    Sato, T.
    Ohmura, T.
    Toyota, J.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S342 - S343
12345